Justin Sabet-Peyman joined KKR in 2008 and is a member of the Health Care industry team within KKR’s Private Equity platform. He currently serves on the boards of directors of EchoNous (Signostics), Ebb Therapeutics and Arbor Pharmaceuticals. He formerly served on the board of Lake Region Medical before its sale to Greatbatch and has also been involved with KKR’s investments in Bayer Diabetes Care, Marvell Technology Group, Panasonic Healthcare, Go Daddy, and NXP. Prior to joining KKR, Justin worked at McKinsey & Company where he served several corporate and private equity clients. Justin received his B.S. and M.S. from Stanford University where he graduated as the Henry Ford II Scholar of the School of Engineering and was a Mayfield Fellow.
Share this post